Aardvark Therapeutics, Inc. Common Stock (AARD) News

Latest headlines that mention AARD, newest first · each headline opens the original publisher

AARD quote

Last price: $1.08
Day change: -22.30%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

AARD headlines

latest coverage

Investing.com 16h ago

Aardvark Therapeutics stock rating cut to Perform by Oppenheimer

General T3AARD OPY

Seeking Alpha News 3d ago

Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials Transcript

General T2AARD

Investing.com 18d ago

Aardvark Therapeutics appoints David Zhang to board of directors

General T3AARD

Investing.com 1mo ago

Aardvark Therapeutics COO Nelson Sun sells $394,957 in shares

General T3AARD

Seeking Alpha 2mo ago

Aardvark Therapeutics GAAP EPS of -$0.66 beats by $0.22

Earnings T2AARD

Seeking Alpha News 5mo ago

Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward

General T2AARD

Investing.com 5mo ago

Aardvark Therapeutics stock tumbles on FDA clinical hold, analyst downgrades

General T3AARD

Investing.com 5mo ago

Morgan Stanley downgrades Aardvark Therapeutics stock rating on FDA hold

General T3AARD MS

Seeking Alpha 5mo ago

Aardvark Therapeutics GAAP EPS of -$0.99

Earnings T2AARD

Also mentioned with AARD

30d

OPY1

Headlines that tag both tickers

AARD news alerts

Get an alert by email or push when a new headline mentions AARD.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.